BD Names R. Andrew Eckert To Board Of Directors
FRANKLIN LAKES, N.J., July 28, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew "Andy" Eckert has been appointed to the company's Board of Directors, effective Sept. 26, bringing the total number of directors to 13.
Mr. Eckert, 55, is the CEO of Valence Health, Inc., a health care information technology and services company that provides clinical integration, population health and value-based care solutions to the health care industry. Prior to Valence, Mr. Eckert was CEO of TriZetto Corp. prior to its acquisition by Cognizant Technology Solutions in November 2014. He has held CEO roles with multiple other companies, including CRC Health Group, Inc., Eclipsys Corporation, SumTotal Systems Inc. and ADAC Laboratories, Inc. He also serves as Chairman of the Board of Directors for Varian Medical Systems, Inc.
"Andy is a proven leader in the growing field of health care information technology, and we believe he will be a valuable contributor to the BD Board of Directors as we move deeper into the digital health space," said Vincent A. Forlenza, chairman, CEO and president of BD.
About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
Contacts: |
|
Kristen Cardillo |
Monique N. Dolecki |
BD Communication |
BD Investor Relations |
201.847.5657 |
201.847.5378 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-names-r-andrew-eckert-to-board-of-directors-300305911.html
SOURCE BD (Becton, Dickinson and Company)
Released July 28, 2016